Table 3.
QoL variable | MZM | DZM | MZF | DZF | DZOS |
---|---|---|---|---|---|
Anxiety |
.09 (− .07/.25) |
.08 (− .12/.26) |
.23 (.12/.33) |
.30 (.17/.40) |
.01 (− .08/.11) |
General health |
.25 (.12/.37) |
.27 (.10/.41) |
.31 (.21/.40) |
.34 (.22/.45) |
.11 (.00/.22) |
Physical functioning |
.12 (− .13/.32) |
.47 (.23/.61) |
.38 (.28/.47) |
.26 (.12/.38) |
.22 (.10/.33) |
Role of physical problems |
.05 (− .11/.20) |
.20 (− .01/.37) |
.26 (.14/.36) |
.30 (.17/.41) |
.02 (− .08/.12) |
Emotional wellbeing |
.23 (.12/.34) |
.18 (− .01/.35) |
.31 (.20/.41) |
.23 (.10/.34) |
.10 (.00/.21) |
Role of emotional problems |
.19 (.05/.31) |
.09 (− .14/.30) |
.19 (.09/.30) |
.32 (.19/.44) |
.05 (− .05/.16) |
Energy/fatigue |
.18 (.05/.30) |
.20 (.01/.37) |
.27 (.16/.37) |
.28 (.15/.40) |
.19 (.09/.29) |
Pain |
.11 (− .02/.24) |
.36 (.19/.50) |
.17 (.06/.27) |
.24 (.12/.35) |
.05 (− .07/.16) |
Social functioning |
.42 (.22/.60) |
.43 (.16/.65) |
.43 (.27/.57) |
.49 (.28/.66) |
.32 (.15/.47) |
Significant twin correlations are given in bold (as indicated by 95% CI not crossing zero). Please note that cross-twin cross trait correlations can be found in Supplementary Table 2
MZM monozygotic male twins, MZF monozygotic female twins, DZM dizygotic male twins, DZF dizygotic female twins, DZOS dizygotic opposite sex twins